Skip to search formSkip to main contentSkip to account menu

Thromboxane A2

Known as: TXA-2, A2, Thromboxane, 9S,11S-Epoxy,15S-Hydroxy-Thromboxa-5Z,13E-Dien-1-Oic Acid 
An eicosanoid and short-lived intermediate product between prostaglandin endoperoxides and thromboxane B2, with prothrombotic and vasoconstrictive… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1988
1988
Hypercholesterolemla Induces adhesion of blood-borne monocytes to vascular endothellum and their subsequent migration Into the… 
Review
1987
Review
1987
Thromboxane A2 (TxA2) appears to be an important mediator of ischemia and hypoxia. Despite its short half-life and the fact that… 
1986
1986
Interactions of ONO3708, a thromboxane (TX) A2 analog, and epithio-methano-TXA2 (sTXA2) or prostaglandins (PGs) were investigated… 
Highly Cited
1983
Highly Cited
1983
We examined the effects of the slow channel Ca++ blocker diltiazem on human platelet aggregation and TXA2 generation. Diltiazem… 
1982
1982
Summary The ability of the ischemic heart to release prostacyclin (PGI2) and thromboxane A2 (TXA2) was studied, together with the… 
1981
1981
The relationship of leukocytes, platelets, and thromboxane A2 (TxA2) to endotoxin-induced lung injury was studied by use of… 
Highly Cited
1981
Highly Cited
1981
Prostacyclin (PGI2) and thromboxane A2 (TxA2), antiaggregating and aggregating agents, may be involved in the control of local… 
1980
1980
All cis-5,8,11,14,17 eicosapentaenoic acid (EPA) inhibits platelet aggregation. The mechanisms for this inhibition are not known… 
Highly Cited
1979
Highly Cited
1979
Platelet secretion induced by certain soluble aggregating agents is associated with thromboxane formation. Activation of… 
1978
1978
During anaphylaxis, or when perfused with arachidonic acid, guinea pig lungs release a vasoactive rabbit aorta-contracting…